Video Experimental Relacionado
Updated: Jul 5, 2026
14:48
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Una perspectiva TRIFfica sobre las lesiones pulmonares agudas
Thomas R Martin1, Mark M Wurfel
1The Medical Research Service of the VA Puget Sound Health Care System and the Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, WA 98108, USA. trmartin@u.washington.edu
Cell
|April 22, 2008
Resumen
La lesión pulmonar aguda (ALI) es una complicación mortal de las infecciones por H5N1 y SARS-CoV. Los investigadores descubrieron que los fosfolípidos oxidados envían señales a través del receptor Toll-like 4 (TLR4) y el desencadenante de la proteína TRIF ALI, lo que ofrece nuevos conocimientos terapéuticos.
Área de la Ciencia:
- Inmunología Inmunología.
- Patología Patología Patología.
- Biología Molecular Biología Molecular
Sus antecedentes:
- La lesión pulmonar aguda (ALI) es una afección grave con alta mortalidad, a menudo asociada con infecciones virales como la gripe aviar H5N1 y el coronavirus SARS.
- Las opciones actuales de tratamiento para la ALI son limitadas, lo que pone de relieve la necesidad de una comprensión más profunda de sus mecanismos moleculares.
Objetivo del estudio:
- Aclarar los desencadenantes moleculares y las vías de señalización involucradas en la patogénesis de la lesión pulmonar aguda.
Principales métodos:
- Investigó el papel de los fosfolípidos oxidados en ALI.
- Examinó la participación del receptor tipo Toll 4 (TLR4) y la proteína adaptadora TRIF en la cascada de señalización.
Principales resultados:
- Se demostró que la señalización de fosfolípidos oxidados a través de TLR4 y TRIF es un desencadenante clave para ALI.
- Identificó una vía molecular específica que contribuye al desarrollo de ILA.
Conclusiones:
- La señalización de fosfolípidos oxidados a través de TLR4 y TRIF es un factor crítico en la patogénesis de ALI.
- Estos hallazgos ofrecen nuevos conocimientos sobre los mecanismos moleculares de la ILA, lo que potencialmente allana el camino para nuevas estrategias terapéuticas.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:23Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...